Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP460910.RAf_b71i7kzBMo7_l7xiFa0omR29Wy4OkNfeYBLQSk_8E130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP460910.RAf_b71i7kzBMo7_l7xiFa0omR29Wy4OkNfeYBLQSk_8E130_provenance.
• NP606214.RAahJT9vW4Px6XD6ETGat4-ieZ7pPjCFtlv3idwKGke4c130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606214.RAahJT9vW4Px6XD6ETGat4-ieZ7pPjCFtlv3idwKGke4c130_provenance.
• NP781627.RAWdy2cjPRQiZO5L5InM2XhnlWoWch4HpXc3vU-_9Sxo4130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781627.RAWdy2cjPRQiZO5L5InM2XhnlWoWch4HpXc3vU-_9Sxo4130_provenance.
• NP873363.RAYb0i1cnSVIs8Gk0EZIz8eDZ1tUhV-vEmP9rDGiHqSu0130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873363.RAYb0i1cnSVIs8Gk0EZIz8eDZ1tUhV-vEmP9rDGiHqSu0130_provenance.
• assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP788007.RABPiM5LSOelMJXhyeYBgxIcitjzgANXjC8tnhp5MqN_U130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788007.RABPiM5LSOelMJXhyeYBgxIcitjzgANXjC8tnhp5MqN_U130_provenance.
• NP863157.RAeIndvTFg-y8e_4jMkYB7yHnZ4CMEJwhSu9gMoWMiW1c130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863157.RAeIndvTFg-y8e_4jMkYB7yHnZ4CMEJwhSu9gMoWMiW1c130_provenance.
• NP863159.RAc9nXW4otA4mdye7W-zrXACqmRqKom_kJpaeU9x5znMc130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863159.RAc9nXW4otA4mdye7W-zrXACqmRqKom_kJpaeU9x5znMc130_provenance.
• NP863164.RAXR59dchbRlOMAdtukj_ExxsLlm-O5d_efXhtP6MuA70130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863164.RAXR59dchbRlOMAdtukj_ExxsLlm-O5d_efXhtP6MuA70130_provenance.
• NP914249.RAAamBJxvK380pXOJxLYNHxOQhXGG_enSXHiylhDlfJe0130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914249.RAAamBJxvK380pXOJxLYNHxOQhXGG_enSXHiylhDlfJe0130_provenance.
• NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_provenance.
• NP863162.RADgdgwex4hrqL_9uXw1R7JmmyF4-uK59j_0rB3Pxqgoc130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863162.RADgdgwex4hrqL_9uXw1R7JmmyF4-uK59j_0rB3Pxqgoc130_provenance.
• NP978713.RAiwF2bbSFBjd1vzRsO7M8mTkY_xNC2TaeOQfkeCbZOi4130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978713.RAiwF2bbSFBjd1vzRsO7M8mTkY_xNC2TaeOQfkeCbZOi4130_provenance.
• NP863156.RAgJBoMrpBQL3tmw5fIaF7ur98N7Q0NIMjNkVYGB52SBE130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863156.RAgJBoMrpBQL3tmw5fIaF7ur98N7Q0NIMjNkVYGB52SBE130_provenance.
• NP863167.RAkkQNx3J-pNlOfzlV7BPExLpOiTgi3zBEWTqBN_Ky6vo130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863167.RAkkQNx3J-pNlOfzlV7BPExLpOiTgi3zBEWTqBN_Ky6vo130_provenance.
• NP863168.RAq2c4Kl4-Y0s7XUMDNYQKWymQNoQzpf2y78R_plKShqM130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863168.RAq2c4Kl4-Y0s7XUMDNYQKWymQNoQzpf2y78R_plKShqM130_provenance.
• NP460984.RAJ-PjRoaZo92n44glSJsoVy6_8yqKEGd09SrOyDks5kk130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP460984.RAJ-PjRoaZo92n44glSJsoVy6_8yqKEGd09SrOyDks5kk130_provenance.
• NP863158.RAJwmH960RUzT_uDvANP6jPDk2zKqEMoU02MBDMEanw-M130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863158.RAJwmH960RUzT_uDvANP6jPDk2zKqEMoU02MBDMEanw-M130_provenance.
• NP863160.RAObe8ZmSPCqpGgvTlBzI1i9nEbOAPDBQMIxGBdzs_k1Y130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863160.RAObe8ZmSPCqpGgvTlBzI1i9nEbOAPDBQMIxGBdzs_k1Y130_provenance.
• NP863166.RAGyRmOXmTjj2RNIWMzaiq0gb56w5kvEvnvW2uFn6GeRE130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863166.RAGyRmOXmTjj2RNIWMzaiq0gb56w5kvEvnvW2uFn6GeRE130_provenance.
• NP787908.RAzMCnL24PBnPNrJhLZTTg-wSEha9UHFn9NFiEUJGbRlk130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787908.RAzMCnL24PBnPNrJhLZTTg-wSEha9UHFn9NFiEUJGbRlk130_provenance.
• NP863155.RA_Yy28zDXRStvVeChlrhlOM48JD6md7rOIuBXGb6NjLE130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863155.RA_Yy28zDXRStvVeChlrhlOM48JD6md7rOIuBXGb6NjLE130_provenance.
• NP863163.RA7YwglUP0uzsD0YlhzItE2yeBHD0Ff8HjMbdSdnjuF5o130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863163.RA7YwglUP0uzsD0YlhzItE2yeBHD0Ff8HjMbdSdnjuF5o130_provenance.
• NP863165.RAwAevJZIh96ibfvtFXwTblKeh-0SC55Y9daeFWMe1zMA130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863165.RAwAevJZIh96ibfvtFXwTblKeh-0SC55Y9daeFWMe1zMA130_provenance.